The partnership will provide funding and scholarships for pharmacists to attend mental health first aid training, and a series of webinars focused on self-care for pharmacists, their staff and patients developed by the NCPA education team.
“HDA and our pharmaceutical distributor members applaud the FDA’s decision to grant an exemption for the DSCSA’s enhanced drug distribution security (EDDS) requirements for eligible trading partners."
Amazon Pharmacy is accelerating its rollout of new pharmacies, offering fast, free delivery of prescription medications in 20 more U.S. cities next year.
By CVS Communications Dept.
21 members of Congress sent a letter to the FDA regarding concerns about DSCSA implementation.
The Pharmaceutical Care Management Association (PCMA) released new research that highlights how the majority of independent pharmacies use PSAOs to help them achieve scale and keep them competitive.
She will lead the company's unified solutions and offerings to life science and biopharma partners, including clinical trials, commercial patient support and health care data and analytics.
The opportunity for pharmacies to fill the country’s health care gap was top of mind during a roundtable discussion conducted by Chain Drug Review at this summer’s NACDS Total Store Expo in Boston.
The Injection Training Video Library is part of Senderra's ongoing commitment to enhancing patient education.
“The U.S. is failing one of its principal obligations as a nation: to protect the health and welfare of its people,” says Dr. Joseph Betancourt, president of the Commonwealth Fund.
Kroger had announced a definitive agreement with Elevance Health for the sale in March.
Innovative RFID-based solution for prefillable syringes (PFS) aims to enhance efficiency and improve traceability during the fill & finish process and product distribution.
CMS’ failure to require timely, sufficient pharmacy reimbursement will lead to closures not seen since the start of Part D and patients will suffer as a result.
Dr. Reddy’s has been granted a license to manufacture Lenacapavir and market it for the current approved indication of HIV treatment in HTE adults with multi-drug resistant HIV.
